Cadila Healthcare Gets DCGI Nod To Conduct Phase III Trials For Two-Dose COVID Vaccine

Shares of Cadila Healthcare Ltd were trading at Rs 563.95 per scrip on BSE, up 0.29 percent from their previous close

‘Brought Several Innovations To The Market For Unmet Needs In Healthcare’: Nitin Parekh, Cadila Healthcare

The recognition of one’s achievements is a motivation to scale newer heights. It also helps the organisation understand the calibre of the team and CFO.

When Struggle Meets Success: Journey Of A CFO

From Academically Poor to a Leading Indian CFO, Nitin Parekh’s life is a lesson in grit and sheer determination to overcome one’s circumstances and rise to the occasion.

Zydus Cadila, Taiwan's TLC Ink Pact To Market Black Fungus Drug In India

Shares of Cadila Healthcare, the listed entity of Zydus Group, were trading at Rs 626.45 per scrip on BSE, up 0.64 per cent from the previous close.

Cadila Healthcare Stocks Rise Over 2%

The pharmaceutical company's stocks were trading 1.98 per cent higher at Rs 442.50 on the BSE.

USFDA Grants Orphan Drug Designation To Zydus Cadila's Saroglitazar Mg

The United States Food and Drug Administration (USFDA) has granted ODD to Saroglitazar Mg, Cadila Healthcare said in a regulatory filing.

Modern CFOs Creating Future Ready Organizations

The top-level CFOs from across the industries came together to talk and discuss the outcomes of ongoing accelerated digitization and the evolving role of CFOs in this disrupted era.

India Approves Human Trials For Second COVID-19 Vaccine Candidate

India's approval for Zydus comes days after privately held Bharat Biotech got a similar green light for human studies for its vaccine candidate.

NPPA Issues Show Cause Notice To Cadila, Lupin, Abbott Healthcare Among Others

Country’s top drugmakers including Abbott Healthcare, Mankind Pharma, Cadila, Lupin and Biocon are under scanner. NPPA has found around 200 'new drugs' which are either being sold by drug makers without applying for price approvals or have been tweaked to escape the provisions under DPCO

Best CFO Awards 2016-17 | Healthy Numbers Are Vital

Every small bit matters for Nitin Parekh, the finance czar at Cadila

Cadila Gets Negative US FDA Observations For Matoda SEZ Unit

The American regulator had in January issued similar notice to the company's Moraiya manufacturing unit

Cadila's Shares Fall After WHO Faults Vaccines Plant Standards

Cadila Healthcare's shares fell on Wednesday after the World Health Organization cited violations of manufacturing and clinical standards at one of the drugmaker's vaccines factory in Gujarat

FIPB Clears 5 FDI Proposals Worth Rs 6,050 Crore; Cadila Healthcare Gets Nod

Government has approved five foreign investment proposals involving an inflow of Rs 6,050 crore including a Rs 5,000-crore plan of Cadila Healthcare for fresh equity infusion

Cadila Gets FDA Warning For Violating Standards At Two Plants

Cadila Healthcare Ltd said it received a warning from US health regulators for violating manufacturing standards at two production sites in India, sending its shares down 17 per cent to its biggest single-day percentage fall

India Expands Medicine Price Control List To Include 39 More Drugs